Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the genomic temporal evolution of multiple myeloma. Dr Maura’s research analyses early genomic drivers using whole genome sequencing (WGS), particularly chromosome 1q gain and hyperdiploidy (HRD), and its impact on clinical outcomes. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.